# ZERBAXA

NDC: 67919-030
Generic name: ceftolozane and tazobactam
Labeler / Manufacturer: Merck Sharp & Dohme LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20141219

FDA application: NDA206829

## Active ingredients

- CEFTOLOZANE SULFATE: 1 g/10mL
- TAZOBACTAM SODIUM: .5 g/10mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67919-030"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67919-030
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=70ac1d90-eff3-4f0b-9f46-5846c571b32f